×

img Accessibility Controls

Technologies Banner

All Technologies

Indigenous Vccine Technology

Implementing Organization

Serum Institute, Pune

Project Overview

DBT-BIRAC-GCI supported Serum Institute of India for the first indigenously development of human papillomavirus vaccine (HPV)-- “CERVAVAC," against the cervical cancer in women

Benefits

Considering the development of the indigenous HPV vaccine, India has the capacity to achieve success in the Cervical Cancer Elimination goal for 90% of coverage among girls up to 15 years old. With the introduction of the indigenous vaccine, the cost barrier being addressed.
Funding Organization
Quick Information
Thrust Areas
Life Sciences & Biotechnology
Focus Area
Vaccines, Infectious Diseases
Status
Currently availble in Indian Market
Output
Status
Currently availble in Indian Market
Patent
Nil
arrowtop
Latest Updates
Loading…